Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity

International Immunopharmacology

Volumn 11, Issue 9, 2011, Pages 1234-1240

  Luo, Feifei ^a   Song, Xiao ^a   Zhang, Yi ^a   Chu, Yiwei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CTL; Curcumin; IFN ; Lung tumor bearing mice

Indexed keywords

CURCUMIN; GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FEMALE; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR; TUMOR IMMUNITY;

ADAPTIVE IMMUNITY; ANIMALS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELLS, CULTURED; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 80051890885     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.04.002     Document Type: Article

References (40)

1. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 3 2007 581 592 (Pubitemid 46359643)
2. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 1 2007 43 66 (Pubitemid 46148091)
3. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 23 1A 2003 363 398 (Pubitemid 36361976)
4. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin and cancer: an "old-age" disease with an "age-old" solution Cancer Lett 267 1 2008 133 164
5. H.P. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med 57 1 1991 1 7
6. M.S. Kim, H.J. Kang, and A. Moon Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells Arch Pharm Res 24 4 2001 349 354 (Pubitemid 33703584)
7. C. Freudlsperger, J. Greten, and U. Schumacher Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB Anticancer Res 28 1A 2008 209 214 (Pubitemid 351362903)
8. C.S. Divya, and M.R. Pillai Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis Mol Carcinog 45 5 2006 320 332
9. S. Lev-Ari, A. Starr, A. Vexler, V. Karaush, V. Loew, and J. Greif Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity Anticancer Res 26 6B 2006 4423 4430 (Pubitemid 46031517)
10. C.C. Su, J.G. Lin, T.M. Li, J.G. Chung, J.S. Yang, and S.W. Ip Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3 Anticancer Res 26 6B 2006 4379 4389
11. S. Shankar, and R.K. Srivastava Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa Carcinogenesis 28 6 2007 1277 1286 (Pubitemid 47062688)
12. D.W. Scott, and G. Loo Curcumin-induced GADD153 gene up-regulation in human colon cancer cells Carcinogenesis 25 11 2004 2155 2164 (Pubitemid 39534853)
13. B.B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R.A. Newman, and C.E. Bueso-Ramos Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin Cancer Res 11 20 2005 7490 7498 (Pubitemid 41507710)
14. J.L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M.T. Huang, and C. Fisher Curcumin is an in vivo inhibitor of angiogenesis Mol Med 4 6 1998 376 383 (Pubitemid 28387896)
15. M.S. Furness, T.P. Robinson, T. Ehlers, R.B. Hubbard 4th, J.L. Arbiser, and D.J. Goldsmith Antiangiogenic agents: studies on fumagillin and curcumin analogs Curr Pharm Des 11 3 2005 357 373 (Pubitemid 40277863)
16. G.C. Jagetia, and B.B. Aggarwal "Spicing up" of the immune system by curcumin J Clin Immunol 27 1 2007 19 35
17. S. Singh, and A. Khar Biological effects of curcumin and its role in cancer chemoprevention and therapy Anticancer Agents Med Chem 6 3 2006 259 270 (Pubitemid 43796643)
18. E. Sikora, A. Bielak-Zmijewska, K. Piwocka, J. Skierski, and E. Radziszewska Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment Biochem Pharmacol 54 8 1997 899 907 (Pubitemid 27404597)
19. X. Gao, J. Kuo, H. Jiang, D. Deeb, Y. Liu, and G. Divine Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro Biochem Pharmacol 68 1 2004 51 61 (Pubitemid 38746541)
20. O. Mandelboim, E. Vadai, M. Fridkin, A. Katz-Hillel, M. Feldman, and G. Berke Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides Nat Med 1 11 1995 1179 1183
21. R.A. Sharma, S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, and H.R. Hewitt Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin Cancer Res 10 20 2004 6847 6854 (Pubitemid 39383033)
22. X. Ren, F. Ye, Z. Jiang, Y. Chu, S. Xiong, and Y. Wang Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells Cell Death Differ 14 12 2007 2076 2084 (Pubitemid 350131157)
23. L.X. Chen, Y.J. He, S.Z. Zhao, J.G. Wu, J.T. Wang, and L.M. Zhu Inhibition of tumor growth and vasculogenic mimicry by cucumin through downregulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model Cancer Biol Ther 11 2 2011 229 235
24. J. Weissenberger, M. Priester, C. Bernreuther, S. Rakel, M. Glatzel, and V. Seifert Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway Clin Cancer Res 16 23 2010 5781 5795
25. E.V. Bowers, J.J. Horvath, J.E. Bond, G.J. Cianciolo, and S.V. Pizzo Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response J Leukoc Biol 86 5 2009 1259 1268
26. T. Feuchtinger, P. Lang, K. Hamprecht, M. Schumm, J. Greil, and G. Jahn Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy Exp Hematol 32 3 2004 282 289 (Pubitemid 38328534)
27. G.Y. Kim, K.H. Kim, S.H. Lee, M.S. Yoon, H.J. Lee, and D.O. Moon Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets J Immunol 174 12 2005 8116 8124
28. V.S. Yadav, K.P. Mishra, D.P. Singh, S. Mehrotra, and V.K. Singh Immunomodulatory effects of curcumin Immunopharmacol Immunotoxicol 27 3 2005 485 497 (Pubitemid 41428840)
29. G.P. Dunn, L.J. Old, and R.D. Schreiber The three Es of cancer immunoediting Annu Rev Immunol 22 2004 329 360 (Pubitemid 38680426)
30. H. Kanzler, F.J. Barrat, E.M. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 13 5 2007 552 559 (Pubitemid 46830615)
31. Ch. Varalakshmi, A.M. Ali, B.V. Pardhasaradhi, R.M. Srivastava, S. Singh, and A. Khar Immunomodulatory effects of curcumin: in-vivo Int Immunopharmacol 8 5 2008 688 700
32. M. Churchill, A. Chadburn, R.T. Bilinski, and M.M. Bertagnolli Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile J Surg Res 89 2 2000 169 175 (Pubitemid 30196521)
33. S. Bhattacharyya, D. Mandal, B. Saha, G.S. Sen, T. Das, and G. Sa Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction J Biol Chem 282 22 2007 15954 15964 (Pubitemid 47100378)
34. H.S. Youn, S.I. Saitoh, K. Miyake, and D.H. Hwang Inhibition of homodimerization of Toll-like receptor 4 by curcumin Biochem Pharmacol 72 1 2006 62 69 (Pubitemid 43810172)
35. S. Kato, Y. Yuzawa, N. Tsuboi, S. Maruyama, Y. Morita, and T. Matsuguchi Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4 J Am Soc Nephrol 15 5 2004 1289 1299 (Pubitemid 38526010)
36. T. Matsuguchi, T. Musikacharoen, T. Ogawa, and Y. Yoshikai Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages J Immunol 165 10 2000 5767 5772
37. W. Kim, Y.Y. Fan, R. Smith, B. Patil, G.K. Jayaprakasha, and D.N. McMurray Dietary curcumin and limonin suppress CD4+ T-cell proliferation and interleukin-2 production in mice J Nutr 139 5 2009 1042 1048
38. D. Ranjan, C. Chen, T.D. Johnston, H. Jeon, and M. Nagabhushan Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling J Surg Res 121 2 2004 171 177 (Pubitemid 39387457)
39. S. Bhattacharyya, D. Md Sakib Hossain, S. Mohanty, G. Sankar Sen, S. Chattopadhyay, and S. Banerjee Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts Cell Mol Immunol 7 4 2010 306 315
40. S. Bhattacharyya, D. Mandal, G.S. Sen, S. Pal, S. Banerjee, and L. Lahiry Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin Cancer Res 67 1 2007 362 370 (Pubitemid 46142796)